[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2016 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 39.14%
YoY- -31.7%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,136,261 618,294 2,189,022 1,606,206 1,090,991 559,195 2,189,312 -35.44%
PBT 37,927 27,777 72,017 67,948 48,025 26,538 112,722 -51.65%
Tax -8,918 -8,519 -26,158 -21,189 -13,914 -8,068 -28,138 -53.54%
NP 29,009 19,258 45,859 46,759 34,111 18,470 84,584 -51.03%
-
NP to SH 28,443 18,923 45,599 46,435 33,374 18,379 84,044 -51.46%
-
Tax Rate 23.51% 30.67% 36.32% 31.18% 28.97% 30.40% 24.96% -
Total Cost 1,107,252 599,036 2,143,163 1,559,447 1,056,880 540,725 2,104,728 -34.85%
-
Net Worth 541,894 544,360 531,169 530,907 524,041 515,906 529,482 1.55%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 20,742 10,368 41,457 33,667 23,302 10,354 77,674 -58.56%
Div Payout % 72.93% 54.79% 90.92% 72.50% 69.82% 56.34% 92.42% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 541,894 544,360 531,169 530,907 524,041 515,906 529,482 1.55%
NOSH 259,279 259,219 259,377 258,979 258,913 258,859 258,915 0.09%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 2.55% 3.11% 2.09% 2.91% 3.13% 3.30% 3.86% -
ROE 5.25% 3.48% 8.58% 8.75% 6.37% 3.56% 15.87% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 438.24 238.52 844.83 620.21 421.37 216.02 845.57 -35.50%
EPS 10.97 7.30 17.60 17.93 12.89 7.10 32.46 -51.51%
DPS 8.00 4.00 16.00 13.00 9.00 4.00 30.00 -58.60%
NAPS 2.09 2.10 2.05 2.05 2.024 1.993 2.045 1.46%
Adjusted Per Share Value based on latest NOSH - 259,146
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 78.84 42.90 151.89 111.45 75.70 38.80 151.91 -35.44%
EPS 1.97 1.31 3.16 3.22 2.32 1.28 5.83 -51.51%
DPS 1.44 0.72 2.88 2.34 1.62 0.72 5.39 -58.55%
NAPS 0.376 0.3777 0.3686 0.3684 0.3636 0.358 0.3674 1.55%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 4.58 4.89 5.30 5.58 5.50 5.76 6.36 -
P/RPS 1.05 2.05 0.63 0.90 1.31 2.67 0.75 25.17%
P/EPS 41.75 66.99 30.12 31.12 42.67 81.13 19.59 65.68%
EY 2.40 1.49 3.32 3.21 2.34 1.23 5.10 -39.52%
DY 1.75 0.82 3.02 2.33 1.64 0.69 4.72 -48.42%
P/NAPS 2.19 2.33 2.59 2.72 2.72 2.89 3.11 -20.86%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 -
Price 4.19 4.72 5.12 5.70 5.62 5.60 6.19 -
P/RPS 0.96 1.98 0.61 0.92 1.33 2.59 0.73 20.05%
P/EPS 38.20 64.66 29.09 31.79 43.60 78.87 19.07 58.97%
EY 2.62 1.55 3.44 3.15 2.29 1.27 5.24 -37.03%
DY 1.91 0.85 3.13 2.28 1.60 0.71 4.85 -46.30%
P/NAPS 2.00 2.25 2.50 2.78 2.78 2.81 3.03 -24.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment